MedTrace Logo

Early-Warning Intervention for Heat and Cold in Older Hypertensive Patients: Impact on Sleep Quality

NCT06045403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 378

Last updated 2024-10-30

No results posted yet for this study

Summary

This cluster-randomized trial, conducted in Tianjin, China, aims to evaluate the effectiveness of integrating a digital health risk early warning tool for heat with self-monitoring. Additionally, the study assesses the effectiveness of combining a digital health risk early warning tool for cold with self-monitoring. Communities from three districts will be randomly assigned to one of three groups: the combined intervention group, the self-monitoring group, and the control group. The primary objective of the study is to evaluate the effectiveness of the intervention in improving sleep quality, as well as understanding its underlying biological mechanisms.

Conditions

Interventions

BEHAVIORAL

Issuing health risk warning for a heat or cold

Whenever a health risk warning for a heat or cold is issued, only the elderly in the combined intervention group will be alerted to the early warning information through the digital heat or cold health risk early warning tool.

DEVICE

A digital heat or cold health risk early warning tool

A WeChat mini-program provides real-time updates on early warnings and health advisories.

BEHAVIORAL

Perform daily self-monitoring of their BP and ECG

Participants in the self-monitoring alone group were instructed to self-measure their BP three times each morning (from 6:00 a.m. to 8:00 a.m.) and evening (from 6:00 p.m. to 8:00 p.m.) at home, and to self-administer ECG measurements twice during the same morning and evening timeframes.

DEVICE

Self-monitoring blood pressure and ECG device

Devices for self-monitoring blood pressure and electrocardiography (ECG).

Sponsors & Collaborators

  • Tiantian Li

    lead OTHER_GOV

Principal Investigators

  • Tiantian Li · National lnstitute of Environmental Health, Chinese Center for Disease Controland Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-02-28
Completion
2024-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06045403 on ClinicalTrials.gov